A. Straumann

Discipline

Psychologie (5) Economies et finances (1)

Type de document

Articles (15) Recensions (3) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

Patients (13) Patients (13) maladie (9) maladie (9) Treatment (7) Human beings (7) thérapie (5) adulte (5) Diagnosis (5) Methods (5) Therapeutics (5) Diagnosis (5) Methods (5) adulte (5) puits (4) Ulcerative colitis (4) Symptoms (4) Swiss (4) Inflammation (4) Crohn's disease (4) Older people (4) Pathogenesis (4) cohorte (4) temps (durée) (3) sécurité (3) enfant (3) index (3) Development (3) Inhibitors (3) Inflammatory bowel diseases (3)

Documents écrit par A. Straumann (15) | parle de A. Straumann (0)

Eosinophilic Esophagitis beyond Eosinophils - an Emerging Phenomenon Overlapping with Eosinophilic Esophagitis: Collegium Internationale Allergologicum (CIA) Update 2023.
V.S. Salvador Nunes et al. (2023)
Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS).
C. Ma et al.
Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis.
E.S. Dellon et al.
A novel proangiogenic B cell subset is increased in cancer and chronic inflammation.
W. van de Veen et al.
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.
I. Hirano et al.
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.
S. Godat et al.
Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn's disease patients.
T. Greuter et al. (2018)
Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).
K. Cheng et al. (18 déc. 2017)
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.
T. Greuter et al.
Current concepts in eosinophilic esophagitis.
D. Simon et al. (2017)
Comparison of different biopsy forceps models for tissue sampling in eosinophilic esophagitis.
C. Bussmann et al.
Prevalence and risk factors for therapy escalation in ulcerative colitis in the Swiss IBD Cohort Study
E. Safroneeva et al. (2015)
Prevalence of extraintestinal manifestations in paediatric patients with Inflammatory Bowel Disease : results from the Swiss IBD Cohort Study
S. Vavricka et al. (2015)
Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.
A.M. Schoepfer et al. (2014)
Fäkales Calprotectin bestimmen : Ein Biomarker, der für die Praxis taugt
C. Beglinger et al. (2011)